El Diario Montañés

El Diario Montañés

Europapress

The Institute of Health Carlos III and IDIVAL have been organizing for more than a decade an annual meeting at the UIMP in Santander that has focused on various aspects related to the organization and management of biosanitary research.

This year, the meeting is considered as a strategic reflection on the model of Institutes of Health Research in our country. This topic will be debated with leaders of our country that are expected to be part of the speakers and audience. 

The meeting this year is entitled: “The Institutes of Health Research: towards an effective translation”. The Director of the Carlos III Health Institute, Jesús Fernández Crespo will participate at the course.

The meeting has three parts, corresponding to the three days of the course, the first will focus on other similar international experiences and their applicability in the Institutes of Health Research; the second part will focus on personalized medicine and the role of the Institutes of Health Research in our country, and the third part will focus on the future of the Institutes of Health Research.

It is hoped that a large part of the Health Research Institutes of our country will be represented among the speakers as well as among the participants, which will allow a promising dialogue on key aspects such as their relevance, the financing model, evaluation systems, integration in the Hospitals as priority elements for excellence and high level of care, socioeconomic return, private participation, etc.

More information: UIMP (enlace)

We invite participants to submit proposals for COST Actions contributing to the scientific, technological, economic, cultural or societal knowledge advancement and development of Europe. Multi- and interdisciplinary proposals are encouraged. 

The open call Action Proposal Submission, Evaluation, Selection and Approval (SESA) procedure is fully science and technology-driven and will ensure a simple, transparent and competitive proposal evaluation and selection process, reflecting the bottom-up, open and inclusive principles of COST. 

Participants planning to submit a proposal for a COST Action will need to refer to the updated SESA guidelines.

The minimum number of countries included in the network has increased to seven COST Full or Cooperating Members. Out of the seven, a minimum of three must be Inclusiveness Target Countries. For more details, please refer to the annex of the updated SESA guidelines. 

Participants will also need to include the updated technical annex, which should not exceed 15 pages. Results will be communicated in April 2018.

2016 submissions

Participants who submitted their proposals in 2016 will need to refer to the 2016 SESA guidelines. The final decision on the approval and funding of the Action proposals collected on 7 December 2016 is expected in June 2017.

The set of COST Implementation Rules outlines procedures and conditions for participating in and setting up COST Actions.

Open until 7^th de september 2017, 12:00h.

For any questions related to the open call, please contact: Paloma González (innovation4@idival.org)

Dr. Jose Maria de la Torre Hernández is an interventional cardiologist at the Marques de Valdecilla University Hospital (HUMV), with more than 20 years of experience as a clinician and researcher, and is currently at MIT at the Institute of Biomedical Engineering within the Laboratory of Professor Elazer R. Edelman with a scholarship granted by IDIVAL. The Massachusetts Institute of Technology, known as the “MIT”, is the best Polytechnic University in the world where 85 Nobel Prizes have crossed.

From MIT, Dr. De la Torre has shared his experience and has showed the Massachusetts Institute of Technology;

De la Torre brings his extensive experience in interventional cardiology to the projects of this pioneering center in advances that combine engineering and health, contributing with his clinical vision to projects in which engineers, biologists, mathematicians and professionals of very diverse profiles work. The knowledge acquired during his stay will return in the clinical practice of Valdecilla.